Paper2434476
Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein.
Cornwell MM and 2 others. J Biol Chem, 1987. Cited by 521 papers, by iCite.
Cite this record
ConductScience Library. Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. Papers, record 2434476. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2434476
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Calcium Channel Blockers | Major topic |
| Carcinoma | Major topic |
| Glycoproteins | Major topic |
| 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | |
| ATP Binding Cassette Transporter, Subfamily B, Member 1 | |
| Cell Line | |
| Diltiazem | |
| Drug Resistance | |
| Humans | |
| Nitrendipine | |
| Quinidine | |
| Verapamil | |
| Vinblastine |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CA07661 | NCI NIH HHS | United States | F32CA007661 | PubMed and NIH |
Source NIH RePORTER
Cited by106
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 521 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38989058 | Mechanistic insights into P-glycoprotein ligand transport and inhibition revealed by enhanced molecular dynamics simulations. | Comput Struct Biotechnol J | 2024 | https://conductscience.org/library/papers/38989058 | PubMed |
| 38706362 | Evaluation of Novel Benzo-annelated 1,4-dihydropyridines as MDR Modulators in Cancer Cells. | Anticancer Agents Med Chem | 2024 | https://conductscience.org/library/papers/38706362 | PubMed |
| 38593161 | Pyrrole-based inhibitors of RND-type efflux pumps reverse antibiotic resistance and display anti-virulence potential. | PLoS Pathog | 2024 | https://conductscience.org/library/papers/38593161 | PubMed |
| 36142724 | 5-Arylidenerhodanines as P-gp Modulators: An Interesting Effect of the Carboxyl Group on ABCB1 Function in Multidrug-Resistant Cancer Cells. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36142724 | PubMed |
| 36046755 | The effect of iron on the expression levels of calcium related gene in cisplatin resistant epithelial ovarian cancer cells. | Explor Target Antitumor Ther | 2021 | https://conductscience.org/library/papers/36046755 | PubMed |
| 35989346 | The effect of the very low dosage diltiazem on tacrolimus exposure very early after kidney transplantation: a randomized controlled trial. | Sci Rep | 2022 | https://conductscience.org/library/papers/35989346 | PubMed |
| 35406579 | Combinations of ATR, Chk1 and Wee1 Inhibitors with Olaparib Are Active in Olaparib Resistant Brca1 Proficient and Deficient Murine Ovarian Cells. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35406579 | PubMed |
| 35240035 | Utilization of Photoaffinity Labeling to Investigate Binding of Microtubule Stabilizing Agents to P-Glycoprotein and β-Tubulin. | J Nat Prod | 2022 | https://conductscience.org/library/papers/35240035 | PubMed |
| 34440646 | The Combined Treatment with Chemotherapeutic Agents and the Dualsteric Muscarinic Agonist Iper-8-Naphthalimide Affects Drug Resistance in Glioblastoma Stem Cells. | Cells | 2021 | https://conductscience.org/library/papers/34440646 | PubMed |
| 32857790 | Investigation of physiological and molecular mechanisms conferring diurnal variation in auxinic herbicide efficacy. | PLoS One | 2020 | https://conductscience.org/library/papers/32857790 | PubMed |
| 32403277 | Search for ABCB1 Modulators Among 2-Amine-5-Arylideneimidazolones as a New Perspective to Overcome Cancer Multidrug Resistance. | Molecules | 2020 | https://conductscience.org/library/papers/32403277 | PubMed |
| 31680972 | 2-APB and CBD-Mediated Targeting of Charged Cytotoxic Compounds Into Tumor Cells Suggests the Involvement of TRPV2 Channels. | Front Pharmacol | 2019 | https://conductscience.org/library/papers/31680972 | PubMed |
| 31530935 | ABC-transporter upregulation mediates resistance to the CDK7 inhibitors THZ1 and ICEC0942. | Oncogene | 2020 | https://conductscience.org/library/papers/31530935 | PubMed |
| 31367189 | Modulation of doxorubicin-induced expression of the multidrug resistance gene in breast cancer cells by diltiazem and protection against cardiotoxicity in experimental animals. | Cancer Cell Int | 2019 | https://conductscience.org/library/papers/31367189 | PubMed |
| 30669343 | Organoselenium Compounds as Novel Adjuvants of Chemotherapy Drugs-A Promising Approach to Fight Cancer Drug Resistance. | Molecules | 2019 | https://conductscience.org/library/papers/30669343 | PubMed |
| 29963035 | Identification of a Novel Polyamine Scaffold With Potent Efflux Pump Inhibition Activity Toward Multi-Drug Resistant Bacterial Pathogens. | Front Microbiol | 2018 | https://conductscience.org/library/papers/29963035 | PubMed |
| 29236701 | Anti-leukemic activity of bortezomib and carfilzomib on B-cell precursor ALL cell lines. | PLoS One | 2017 | https://conductscience.org/library/papers/29236701 | PubMed |
| 28243063 | Novel 5-oxo-hexahydroquinoline derivatives: design, synthesis, in vitro P-glycoprotein-mediated multidrug resistance reversal profile and molecular dynamics simulation study. | Drug Des Devel Ther | 2017 | https://conductscience.org/library/papers/28243063 | PubMed |
| 28210973 | Renal Drug Transporters and Drug Interactions. | Clin Pharmacokinet | 2017 | https://conductscience.org/library/papers/28210973 | PubMed |
| 28036031 | Drug Transporter Expression and Activity in Human Hepatoma HuH-7 Cells. | Pharmaceutics | 2016 | https://conductscience.org/library/papers/28036031 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2434476
GET https://conductscience.org/api/papers/v1/2434476/cited_by?page=2